This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and +6.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Q1 FFO Meet Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 0.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Ashford Hospitality Trust (AHT) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Ashford Hospitality Trust (AHT) delivered FFO and revenue surprises of -84.91% and 1.82%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Alexander's (ALX) Q1 FFO Beat Estimates
by Zacks Equity Research
Alexander's (ALX) delivered FFO and revenue surprises of 13.73% and 1.94%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
CubeSmart (CUBE) Tops Q1 FFO and Revenue Estimates
by Zacks Equity Research
CubeSmart (CUBE) delivered FFO and revenue surprises of 3.23% and 2.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Soars 6.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Global Medical REIT (GMRE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO per share estimate revisions may not translate into further price increase in the near term.
Global Medical REIT (GMRE) Q3 FFO and Revenues Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.35% and 1.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Postal Realty Trust (PSTL) Q3 FFO and Revenues Top Estimates
by Zacks Equity Research
Postal Realty Trust (PSTL) delivered FFO and revenue surprises of 15.38% and 6.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Prologis (PLD) Q3 FFO Beat Estimates
by Zacks Equity Research
Prologis (PLD) delivered FFO and revenue surprises of 4.38% and 0.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
GMRE vs. CUBE: Which Stock Is the Better Value Option?
by Zacks Equity Research
GMRE vs. CUBE: Which Stock Is the Better Value Option?
GMRE vs. CDP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GMRE vs. CDP: Which Stock Is the Better Value Option?
GMRE or CDP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMRE vs. CDP: Which Stock Is the Better Value Option?
Healthpeak Properties' Stock Rises 31% in 6 Months: Here's How
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.
Reasons to Add Healthpeak Properties (DOC) to Your Portfolio Now
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC).
GMRE vs. CDP: Which Stock Is the Better Value Option?
by Zacks Equity Research
GMRE vs. CDP: Which Stock Is the Better Value Option?
Global Medical REIT (GMRE) Meets Q2 FFO Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 2.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
National Storage (NSA) Q2 FFO and Revenues Lag Estimates
by Zacks Equity Research
National Storage (NSA) delivered FFO and revenue surprises of -1.59% and 2.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Realty Trust (HR) Q2 FFO Match Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of 0% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
NNN REIT (NNN) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
NNN REIT (NNN) delivered FFO and revenue surprises of 1.20% and 0.75%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Customers Bancorp (CUBI) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Customers Bancorp (CUBI) delivered earnings and revenue surprises of 2.76% and 7.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 0.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Q1 FFO Match Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DiamondRock Hospitality (DRH) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of 6.25% and 2.51%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
by Zacks Equity Research
Global Medical REIT (GMRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 8.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?